- Justice Department charges 15 for $90M+ in alleged healthcare fraud, expands strike force
- UnitedHealth’s PBM names CFO
- Tennessee becomes 2nd state to ban PBMs from owning pharmacies
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- 40% lower physician distress, 245% more violence reporting: Workforce retention strategies gaining traction
- 15 new behavioral health study findings to know
- APRN charged in $1.35M Medicare fraud scheme
- Florida woman faces charges of practicing unlicensed dentistry
- GI of the Rockies launches AI-powered care program
- Deputy injured in Indiana hospital shooting
- Legacy Health-backed insurer PacificSource to exit ACA market, pull out of Montana entirely
- Expanded federal scrutiny reshapes how hospitals govern risk, compliance
- The instability compounding the anesthesiologist shortage
- ADA proposes standards on dental cartridges, water quality
- The unraveling of prior authorization: 5 things to know
- The hospital bad debt and charity care crisis: 20 things to know
- As AI identifies more at-risk patients, health systems face a capacity challenge
- 5 GI power players
- 4 dental insurance updates to know
- Federal appeals court overturns EPA fluoride ruling: 5 notes
- What payers don’t understand about ASC spine surgery
- 3 men sentenced for $6.9M orthotic DME fraud scheme
- What will outpatient cardiology look like in 10 years?
- 15 leadership moves across 4 specialties
- Dental Medicaid disenrollment could cause $86M in added costs
- Park Dental opens Minnesota practice
- AI is about to break healthcare’s scarcity model — if we let it
- The most underrated threat in digital health
- Tennessee orthodontic practice opens 2 locations
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Leaders sound off on overrated ASC trends
- Dental hygienist employment reaches 222,000: State-by-state breakdown
- Vitana Pediatric & Orthodontic Partners adds 1st Maryland practice
- 10 highest-paying states for dental hygienists in 2026
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Novartis, AbbVie plan summer layoffs on opposite coasts
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Industry Voices—From claims to compassion: Reclaiming patient advocacy in revenue cycle
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- AbbVie, GSK race up patient reputation leaderboard in the UK
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- 3 Medical Routines That Older People May Not Need
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- Acadia psychiatric hospital faces abuse lawsuits
- Massachusetts behavioral health clinics to pay $1.4M to settle fraud allegations
- From 50 days to 7: How 1 system cut behavioral health intake wait times
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- Northwell hospital launches in-home behavioral health services
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Health Tech Weekly Rundown: Prime Healthcare expands virtual sitting tech; CVS Health studies seniors' digital health needs
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- House and Senate Democrats move to overturn CMS’ WISeR AI prior auth pilot
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Democratic senators share plans for Medicare home care benefit, long-term care reform
- GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
- Ipsen details growing pains as teens transition to adult care
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
- Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus
- Watch: The Tug-of-War Over Taxpayer Dollars
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues
- Tarsus taps John Cena for its latest Demodex blepharitis campaign
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Listen to the Latest ‘KFF Health News Minute’
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
- Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Somewhere Between Cacophony and Euphony
- Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
- Rapid Weight Loss Beats Slow and Steady in New Clinical Trial
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Smog Linked To Lewy Body Dementia Risk, Major Study Finds
- NYC Mold Removal Program Cut Asthma ER Cases By A Quarter, Study Says
- Pregnancy Safe For Women With Myasthenia Gravis, Study Concludes
National Institutes of Health (NIH) Director Jay Bhattacharya was on the receiving end of a diversity, equity and inclusion (DEI) firestorm during the COVID panic. He firmly believes the scientific approach to turn discoveries into better health has been corrupted by a new mission and ideology: diversity, equity and inclusion (DEI).
Here is his action plan:
https://thespectator.com/topic/cured-dei-national-institutes-health-jay-bhattacharya-matthew-memoli/
How we cured DEI at the National Institutes of Health
Scientists no longer have to mouth DEI shibboleths to garner funding
By Jay Bhattacharya and Matthew J. Memoli - December 11, 2025Since the National Institutes of Health was founded as a one room laboratory in 1887 its mission was simple; perform biomedical research to enhance health, lengthen life and reduce illness and disability for Americans. Scientists for more than one hundred years have taken this scientific approach to turn discoveries into better health. This mission unites all Americans of every race, color and creed. Everyone wants science that benefits their health.
Over the last decade and a half this mission has been corrupted by a new mission and ideology: diversity, equity and inclusion (DEI). This political ideology was reflected in all aspects of the NIH, including hiring practices, promotion and tenure, employee training, performance reviews, communications, management and, yes, even science.
For its entire history NIH funding decisions were made to reach scientific goals. DEI drove decisions to be made to reach political goals instead, requiring NIH scientists to write DEI statements – de facto loyalty oaths – and researchers outside the NIH applying for grants to write plans for enhancing “diverse perspectives” (another name for a DEI statement). Scientific reviewers were chosen based on DEI criteria, and those making funding decisions received bonuses for promoting DEI.
At the end of every fiscal year, NIH program officers handed out “diversity supplements” to universities, directing money to training programs based partly on scientists’ race, rather than their scientific ability. In 2022, the NIH announced funding for universities to conduct “system-wide” DEI audits to address “shortcomings” in addressing “structural racism.”
Scientists learned that the best way to maximize their chance of a slice of NIH money was to promise that their work would help achieve racial nirvana, however remote from utopian ideological pursuits the proposed work actually was. Most scientists obsequiously complied to avoid the risk of career harm, whether they were true believers or not.
NIH policy was fundamental in the DEI-ification of the nation’s top universities and research centers. Even before the fevered days of 2020, when the mania for DEI at universities reached a fever pitch, scientists were often required to write DEI loyalty oaths to be hired or promoted.
In 2020, at Stanford University, radical students circulated a blacklist of professors they considered guilty of wrongthink and harassed them for their ideological impurity. The administration published an “elimination of harmful language” banned word list, creating a hostile work environment for those whose beliefs fell outside the bounds of orthodox DEI-ism. All of this occurred with the approval and even applause of university leaders. Stanford was not alone; top universities embraced similar policies.
None of this reorientation of the NIH and the universities toward DEI translated into improving the health status of Americans. Between 2011 and 2019, life expectancies of nearly every racial group in the US flatlined. All Americans shared in the expanding chronic disease crisis that has made America among the least healthy economically developed nations on earth. Chronic disease does not discriminate and DEI is not the solution.
NIH’s devotion to DEI ended when President Trump took office in January 2025. At the NIH, we dismantled the DEI apparatus and refocused the NIH on its age-old mission. We oversaw a large-scale effort by all parts of NIH to eliminate DEI from its processes, including eliminating loyalty oaths and other DEI statements, removing DEI from performance reviews, hiring and promotion, and purging DEI from all facets of scientific review, notices of funding opportunity (NOFO) and grant decision making.
Though activist courts have restricted our ability to excise many DEI-focused grants from our portfolio, NIH has now terminated hundreds of NOFOs and modified the terms of more than 6,000 grants that contain unscientific DEI-related statements, projects and methods. Because DEI was so deeply embedded in the NIH’s portfolio, it will take some time to complete the work, but by the end of this fiscal year, we will have restored merit and science-based research to their rightful place at the NIH.
We continue to enthusiastically support research that advances the health of all Americans, regardless of their age, race, ethnicity, sex, sexual orientation, or other characteristics. We will unapologetically invest in rigorous science – research that genuinely improves the health of minority populations, rather than serving political ideologies that misuse taxpayer resources.
The NIH will not fund research based on ideologies that promote differential treatment of people based on race or ethnicity, nor will we fund studies exploring broad, poorly defined concepts such as racial microaggressions or implicit bias. Such work diverts resources away from projects that advance the health and longevity of all Americans, including minority populations.
So that the NIH never again strays from its mission, we have established new formal priorities for the NIH, with DEI removed and gold standard science leading the way. Scientists will no longer have to mouth DEI shibboleths to garner funding but instead propose excellent science that helps make America healthy again.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















